Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Clinical and Translational Oncology
Published in: Clinical and Translational Oncology 12/2013

01-12-2013 | Clinical Guides in Oncology

SEOM clinical guidelines for the treatment of nasopharyngeal carcinoma 2013

Authors: R. Mesía, M. Pastor, J. J. Grau, E. del Barco

Published in: Clinical and Translational Oncology | Issue 12/2013

Login to get access

Abstract

Nasopharyngeal carcinoma cases are not frequently encountered in our environment. Local stages are treated with radiotherapy. For advanced local stages, the association of chemotherapy with radiotherapy improves the rates of survival. In the case of metastatic disease stages, treatment requires platinum-based chemotherapy and patients may achieve a long survival time.
Appendix
Available only for authorised users
Literature
1.
Ferlay J, Bray F, Pisani P, Parkin DM. GLOBOCAN 2002 cancer incidence, mortality and prevalence worldwide IARC CancerBase N. 5, version 2.0. Lyon:IARC Press; 2004.
2.
Shanmugaratnam K, Sobon LH. The World Health Organitation histological classification of tumours of the upper repiratory tract and ear. A comentary on the second edition. Cancer. 1993;71:2689–97.PubMedCrossRef
3.
Xeng XK, Chen LH, Wang OS, Fu FB. Influence of (18F) fluorodeoxyglucose positron emission tomography on salvage treatment decision making for locally persistent nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 2006;65(4):1020–5.CrossRef
4.
Classification TNM. En: American joint committee on cancer: AJCC cancer staging handbook. 7th ed. New York: Springer; 2010.
5.
Fu KK. Combined radiotherapy and chemotherapy for nasopharyngeal carcinoma. Semin Radiat Oncol. 1998;8(4):247–53.PubMedCrossRef
6.
Thephamongkol K, Zhou J, Browman G, Wong RKW, Chan JCK, Zeng Y, et al. Chemo-radiotherapy versus radiotherapy alone for nasopharyngeal carcinoma: a meta-analysis of 78 randomized controlled trials from English and not-English databases (abstract). Proc Am Soc Clin Oncol. 2004;23:491a.
7.
Baujat B, Audry H, Bourhis J, Chan AT, Onat H, Chua DT et al. Chemotherapy as an adjunct to radiotherapy in locally advanced nasopharyngeal carcinoma. Cochrane Database Syst Rev. 2006;8(4):1–24.
8.
Bae WK, Hwang JE, Shim HJ, Cho SH, Lee JK, Lim SC, et al. Phase II study of docetaxel, cisplatin, and 5:FU induction chemotherapy followed by chemoradiotherapy in locoregionally advanced nasopharyngeal cancer. Cancer Chemother Pharmacol. 2010;65:589–95.PubMedCrossRef
Metadata
Title
SEOM clinical guidelines for the treatment of nasopharyngeal carcinoma 2013
Authors
R. Mesía
M. Pastor
J. J. Grau
E. del Barco
Publication date
01-12-2013
Publisher
Springer Milan
Published in
Clinical and Translational Oncology / Issue 12/2013
Print ISSN: 1699-048X
Electronic ISSN: 1699-3055
DOI
https://doi.org/10.1007/s12094-013-1094-1

Other articles of this Issue 12/2013

Clinical and Translational Oncology 12/2013 Go to the issue

Clinical Guides in Oncology

SEOM Clinical Guidelines for the systemic treatment of early breast cancer 2013

Clinical Guides in Oncology

SEOM clinical guidelines for the management of metastatic breast cancer 2013

Clinical Guides in Oncology

SEOM clinical guidelines for the treatment of head and neck cancer (HNC) 2013

Clinical Guides in Oncology

SEOM Clinical guidelines for the treatment of advanced colorectal cancer 2013

Clinical Guides in Oncology

SEOM guide to antiemetic prophylaxis in cancer patients treated with chemotherapy 2013

Clinical Guides in Oncology

SEOM clinical guidelines for the adjuvant treatment of colorectal cancer 2013
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits